Startup seeks partners to advance virus therapeutics
Phytoption LLC, a Purdue University-affiliated startup, is advancing the development of antiviral therapeutics in the fight against COVID-19 and other viral diseases. (Image provided)
WEST LAFAYETTE, Ind. – A Purdue University-affiliated startup is advancing the development of antiviral therapeutics in the fight against COVID-19 and other viral diseases.
Phytoption LLC, in the Purdue Research Park, has been working on the commercialization of Purdue initiated OHPP nanotechnology that significantly boosts drug solubility. A soluble niclosamide drug formulation has been developed using such technology.
Niclosamide, a drug used to treat tapeworms, has been found to have a broad-spectrum antiviral effect against many viruses including SARS-CoV-2, the virus that causes the COVID-19 pandemic. But the drug itself has limited potential because its structure makes it difficult to dissolve and for patients to absorb, especially in c
Wabash National set to open collaboration space in Purdue s Discovery Park District
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.
Purdue-affiliated startup looks to restore discarded kidneys for transplant
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.
Purdue Research Foundation partners with IdentifySensors Biologics for COVID-19 technology
purdue.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from purdue.edu Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open. view more
Credit: Purdue University/Chris Adam
WEST LAFAYETTE, Ind. - IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue s Discovery Park District.
As the COVID pandemic was about to break around the globe, IdentifySensors, the parent company of IdentifySensors Biologics, had approached Purdue to help them develop a nanosensor designed to detect spoilage and specific pathogens in the food supply chain.